|
|
|
Volumn 80, Issue 3, 2001, Pages
|
|
High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BILIRUBIN;
IODINE 131;
MONOCLONAL ANTIBODY;
RITUXIMAB;
THYROTROPIN;
B CELL LYMPHOMA;
BILIRUBIN BLOOD LEVEL;
BONE MARROW SUPPRESSION;
CANCER IMMUNOTHERAPY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG MEGADOSE;
FEVER;
HUMAN;
LIVER FUNCTION;
NAUSEA;
NEUTROPENIA;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIOIMMUNOTHERAPY;
RELAPSE;
THYROTROPIN BLOOD LEVEL;
ANTIBODIES, MONOCLONAL;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IODINE RADIOISOTOPES;
LYMPHOMA, B-CELL;
RADIOIMMUNOTHERAPY;
RADIOPHARMACEUTICALS;
REMISSION INDUCTION;
SALVAGE THERAPY;
TISSUE DISTRIBUTION;
TREATMENT OUTCOME;
WHOLE-BODY IRRADIATION;
|
|
EID: 0035195995
PISSN: 09458077
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (3)
|
